Examining the performance of three ballast water compliance monitoring devices for quantifying live organisms in both regulated size classes (≥50 μm and ≥10-<50 μm).

A number of ballast water compliance monitoring devices (CMDs) have been made commercially available to verify the efficacy of ballast water management systems by quantifying the living organisms for both plankton size classes (≥50 μm and ≥10-<50 μm). This study aimed to examine whether new CMDs can provide a reliable indication of compliance regarding Regulation D-2 and to evaluate their performance for indicative analysis of organisms by assessing their accuracy (comparison to microscopy) and precision (comparison within measurement). Challenge fresh water samples were collected in four locations of Lake Ontario, Canada, whereas marine challenge water samples were collected around the Bay of Fundy, New Brunswick, Canada.

Reflecting on the 11th International Equine Infectious Diseases Conference.

Julia Kydd, Martin Nielsen and Andrew Waller highlight some of the key presentations given at last year's 11th International Equine Infectious Diseases Conference, which was held virtually.

Assessing the performance of four indicative analysis devices for ballast water compliance monitoring, considering organisms in the size range ≥10 to <50 μm.

To minimize the global transfer of harmful aquatic organisms and pathogens, the International Maritime Organization (IMO) has introduced the standard in Regulation D-2 to limit the number of viable organisms in ballast water discharged by ships. To meet the standard, many ships are installing ballast water management systems. Concurrently, regulators are looking for indicative analysis devices able to assess compliance with Regulation D-2, producing rapid, accurate and reliable results while being easy to operate.

Predictive risk factors of adverse perinatal outcomes following blunt abdominal trauma in pregnancy.

Background: The primary objective was to identify predictive risk factors of preterm delivery following blunt abdominal trauma. The secondary objective was to identify risk factors of other adverse outcomes, Neonatal Intensive Care Unit (NICU) admission, placental abruption, fetal demise, and Cesarean Delivery (CD).

Methods: This retrospective study included pregnant patients with gestational age (GA) ≥23 weeks who presented after blunt abdominal trauma to Richmond University Medical Center from October 2015 to January 2020.